4.6 Article

Standardizing Vitamin D Assays: The Way Forward

期刊

JOURNAL OF BONE AND MINERAL RESEARCH
卷 29, 期 8, 页码 1709-1714

出版社

WILEY
DOI: 10.1002/jbmr.2252

关键词

VITAMIN D; STANDARDIZATION; VITAMIN D STANDARDIZATION PROGRAM; VDSP; 25-HYDROXYVITAMIN D

资金

  1. NIH National Center on Minority Health and Health Disparities (NCMHD) Comprehensive Centers of Excellence [1P60/R01 MD 003428-01]

向作者/读者索取更多资源

For a number of years it has been widely assumed that measurement of serum 25-hydroxyvitamin D [25(OH)D] concentration is the best approach to assessing an individual's vitamin D status.((1,2)) However, it has also been recognized that there is substantial within-assay variation in 25(OH)D measurement and even greater between-assay variability.((3-5)) Such assay variation clearly confounds attempts to define what constitutes the diagnosis of hypovitaminosis D. Importantly, assay variability makes pooling of 25(OH)D results from different studies in systematic reviews for the specific purpose of determining dose-response and/or clinical cut points at best problematic. Therefore, to develop and implement evidence-based clinical guidelines, it is essential that 25(OH)D measurement be standardized in both clinical and research laboratories. In this Perspective we outline a way forward toward achieving this goal-the Vitamin D Standardization Program (VDSP). (C) 2014 American Society for Bone and Mineral Research

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据